{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:54:35Z","timestamp":1760622875626,"version":"3.37.3"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1124\/jpet.113.203141","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T02:39:23Z","timestamp":1361414363000},"page":"180-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chromatin Remodeling by Rosuvastatin Normalizes TSC2-\/meth Cell Phenotype through the Expression of Tuberin"],"prefix":"10.1016","volume":"345","author":[{"given":"Elena","family":"Lesma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Ancona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Orpianesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Grande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Di Giulio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfredo","family":"Gorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.113.203141_bib1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)61720-8","article-title":"The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms","volume":"159","author":"Arbiser","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1124\/jpet.113.203141_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clim.2005.06.014","article-title":"In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells","volume":"117","author":"Bessler","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1124\/jpet.113.203141_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.113.203141_bib4","doi-asserted-by":"crossref","first-page":"H3158","DOI":"10.1152\/ajpheart.01354.2006","article-title":"Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation","volume":"292","author":"Bulhak","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/jpet.113.203141_bib5","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2119\/2006-00091.Carelli","article-title":"Survivin expression in tuberous sclerosis complex cells","volume":"13","author":"Carelli","year":"2007","journal-title":"Mol Med"},{"key":"10.1124\/jpet.113.203141_bib6","doi-asserted-by":"crossref","first-page":"32493","DOI":"10.1074\/jbc.C300226200","article-title":"Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner","volume":"278","author":"Castro","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.113.203141_bib7","first-page":"10","article-title":"The statins as anticancer agents","volume":"9","author":"Chan","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1124\/jpet.113.203141_bib8","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/nrc1751","article-title":"Statins and cancer prevention","volume":"5","author":"Demierre","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/jpet.113.203141_bib9","doi-asserted-by":"crossref","first-page":"9878","DOI":"10.1158\/0008-5472.CAN-07-1394","article-title":"Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR\/S6 kinase activity","volume":"67","author":"Finlay","year":"2007","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.113.203141_bib10","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1158\/1535-7163.MCT-09-0055","article-title":"Tsc2(+\/-) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor","volume":"8","author":"Finlay","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/jpet.113.203141_bib11","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S1097-2765(03)00220-X","article-title":"Insulin activation of Rheb, a mediator of mTOR\/S6K\/4E-BP signaling, is inhibited by TSC1 and 2","volume":"11","author":"Garami","year":"2003","journal-title":"Mol Cell"},{"key":"10.1124\/jpet.113.203141_bib12","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1124\/jpet.113.203141_bib13","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1083\/jcb.200405130","article-title":"TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase","volume":"167","author":"Goncharova","year":"2004","journal-title":"J Cell Biol"},{"key":"10.1124\/jpet.113.203141_bib14","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1128\/MCB.01061-10","article-title":"mTORC2 is required for proliferation and survival of TSC2-null cells","volume":"31","author":"Goncharova","year":"2011","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.113.203141_bib15","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/jpet.107.123679","article-title":"Reparixin, an inhibitor of CXCR2 function, attenuates inflammatory responses and promotes recovery of function after traumatic lesion to the spinal cord","volume":"322","author":"Gorio","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.113.203141_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.it.2006.12.003","article-title":"Statins and the vascular endothelial inflammatory response","volume":"28","author":"Greenwood","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1124\/jpet.113.203141_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM198807073190105","article-title":"HMG-CoA reductase inhibitors for treatment of hypercholesterolemia","volume":"319","author":"Grundy","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.113.203141_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR pathway in human disease","volume":"37","author":"Inoki","year":"2005","journal-title":"Nat Genet"},{"key":"10.1124\/jpet.113.203141_bib19","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"key":"10.1124\/jpet.113.203141_bib20","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1365-2249.2012.04564.x","article-title":"Inhibitory effect of statins on inflammatory cytokine production from human bronchial epithelial cells","volume":"168","author":"Iwata","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1124\/jpet.113.203141_bib21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1038\/nrd1901","article-title":"Anti-inflammatory effects of statins: clinical evidence and basic mechanisms","volume":"4","author":"Jain","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.113.203141_bib22","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ejca.2005.03.023","article-title":"Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes","volume":"41","author":"Jiang","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1124\/jpet.113.203141_bib23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrg816","article-title":"The fundamental role of epigenetic events in cancer","volume":"3","author":"Jones","year":"2002","journal-title":"Nat Rev Genet"},{"key":"10.1124\/jpet.113.203141_bib24","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2567.2010.03269.x","article-title":"Simvastatin induces Foxp3+ T regulatory cells by modulation of transforming growth factor-\u03b2 signal transduction","volume":"130","author":"Kim","year":"2010","journal-title":"Immunology"},{"key":"10.1124\/jpet.113.203141_bib25","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1136\/gut.2011.237495","article-title":"Statins augment the chemosensitivity of colorectal cancer cells inducing epigenetic reprogramming and reducing colorectal cancer cell \u2018stemness\u2019 via the bone morphogenetic protein pathway","volume":"60","author":"Kodach","year":"2011","journal-title":"Gut"},{"key":"10.1124\/jpet.113.203141_bib27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/35010550","article-title":"The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho","volume":"2","author":"Lamb","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1124\/jpet.113.203141_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2210-9-8","article-title":"Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models","volume":"9","author":"Lee","year":"2009","journal-title":"BMC Pharmacol"},{"key":"10.1124\/jpet.113.203141_bib29","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0002-9440(10)61198-4","article-title":"Isolation and growth of smooth muscle-like cells derived from tuberous sclerosis complex-2 human renal angiomyolipoma: epidermal growth factor is the required growth factor","volume":"167","author":"Lesma","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1124\/jpet.113.203141_bib30","doi-asserted-by":"crossref","first-page":"e3558","DOI":"10.1371\/journal.pone.0003558","article-title":"Anti-EGFR antibody efficiently and specifically inhibits human TSC2-\/- smooth muscle cell proliferation. Possible treatment options for TSC and LAM","volume":"3","author":"Lesma","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1124\/jpet.113.203141_bib31","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.2353\/ajpath.2009.080799","article-title":"The methylation of the TSC2 promoter underlies the abnormal growth of TSC2 angiomyolipoma-derived smooth muscle cells","volume":"174","author":"Lesma","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1124\/jpet.113.203141_bib32","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1038\/sj.onc.1209691","article-title":"Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways","volume":"25","author":"Liu","year":"2006","journal-title":"Oncogene"},{"key":"10.1124\/jpet.113.203141_bib33","doi-asserted-by":"crossref","first-page":"38362","DOI":"10.1074\/jbc.M110.141168","article-title":"Rapamycin inhibits cytoskeleton reorganization and cell motility by suppressing RhoA expression and activity","volume":"285","author":"Liu","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.113.203141_bib34","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1248\/bpb.34.1684","article-title":"Rho kinase inhibition by fasudil has anti-inflammatory effects in hypercholesterolemic rats","volume":"34","author":"Ma","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1124\/jpet.113.203141_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.amjcard.2007.08.035","article-title":"Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels","volume":"101","author":"Ai","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1124\/jpet.113.203141_bib36","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1476-4598-8-38","article-title":"Equivalent benefit of mTORC1 blockade and combined PI3K-mTOR blockade in a mouse model of tuberous sclerosis","volume":"8","author":"Pollizzi","year":"2009","journal-title":"Mol Cancer"},{"key":"10.1124\/jpet.113.203141_bib37","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(98)05917-0","article-title":"Inhibition of proinflammatory cytokine production by pravastatin","volume":"353","author":"Rosenson","year":"1999","journal-title":"Lancet"},{"key":"10.1124\/jpet.113.203141_bib38","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1158\/0008-5472.CAN-04-3465","article-title":"Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells","volume":"65","author":"Sirchia","year":"2005","journal-title":"Cancer Res"},{"key":"10.1124\/jpet.113.203141_bib39","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.cub.2004.06.054","article-title":"Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton","volume":"14","author":"Sarbassov","year":"2004","journal-title":"Curr Biol"},{"key":"10.1124\/jpet.113.203141_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/physrev.2001.81.1.153","article-title":"Small GTP-binding proteins","volume":"81","author":"Takai","year":"2001","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.113.203141_bib41","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.96.15.8681","article-title":"CpG island methylator phenotype in colorectal cancer","volume":"96","author":"Toyota","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.113.203141_bib42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S1357-4310(98)01245-3","article-title":"The genetic basis of tuberous sclerosis","volume":"4","author":"Young","year":"1998","journal-title":"Mol Med Today"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524185771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524185771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.113.203141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:20:50Z","timestamp":1739985650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524185771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0022356524185771"],"URL":"https:\/\/doi.org\/10.1124\/jpet.113.203141","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chromatin Remodeling by Rosuvastatin Normalizes TSC2-\/meth Cell Phenotype through the Expression of Tuberin","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.113.203141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}